Ipragliflozin Catalog No.:M10333-10 31)23-19(33-2)13-17(28)14-20(23)35-27/h4-14
Pay in 4 interest-free payments of $21.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Live Spec
Ipragliflozin Catalog No.:M10333-10 31)23-19(33-2)13-17(28)14-20(23)35-27/h4-14Ipragliflozin, also known as ASP1941, is a potent and selective SGLT2 inhibitor for treatment of type 2 diabetes. Ipragliflozin treatment improved glycaemic control when added to metformin therapy and may be associated with weight loss and reductions in blood pressure compared to placebo. Ipragliflozin improves not only hyperglycemia but also diabetes obesity associated metabolic abnormalities in type 2 diabetic mice. It was approved for use in Japan
Store: nyherosfund.org · Domain: nyherosfund.org
























